Clinical trial
Darbepoetin Administration to Preterm Infants
NCT00334737 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00334737 |
|---|---|
| Title | Darbepoetin Administration to Preterm Infants |
| Official title | A Randomized, Masked, Placebo Controlled Study to Assess the Safety and Efficacy of Darbepoetin Alfa Administered to Preterm Infants |
| Lead sponsor | University of New Mexico, Other |
| Collaborators | Thrasher Research Fund University of Colorado, Denver Intermountain Health Care, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infant, Newborn |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa Injection, erythropoietin alfa injection, sham injection |
| Enrollment | 102 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2013 |
| Completion | Jun 1, 2014 |
| First posted | Jun 8, 2006 |
| Last update posted | Feb 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: